AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2010
Mar 5, 2010
33882_dirs_2010-03-05_b4a0a874-cede-4252-8b77-41c150d2026d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2010-02-24
Reporting Person: Lawrence Cameron William (Principal Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 475 | Indirect |
| Common Stock | 2400 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| stock option (right to buy) | $3.00 | 2015-12-31 | Common Stock (5625) | Direct | |
| Stock option (right to buy) | $22.28 | 2019-12-31 | Common stock (2500) | Direct |
Footnotes
F1: 1,875 shares are exercisable on each of December 31, 2009, 2010, 2011 and 2012.
F2: The stock options vest monthly over 4 years
More from ACHIEVE LIFE SCIENCES, INC.
Annual Report
2026
Jun 8
Proxy Solicitation & Information Statement
2026
Jun 8
Board/Management Information
2026
Jun 2
Interim / Quarterly Report
2026
May 12
Board/Management Information
2026
May 12
Capital/Financing Update
2026
Apr 16
Annual Report
2026
Mar 24
Earnings Release
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30